In order to eliminate shortages of medicines in Mexican social security institute (IMSS) hospitals throughout the country, the agency will purchase drugs worth 6 billion pesos ($80 million) this year, according to IMSS administrative director Gerardo Ruiz Esparza.
Drug prescriptions are provided free of charge for some 300,000 consultations, said Mr Ruiz Esparza, who also promised that there would be speedier processing of patients, sufficient medicines and doctors as well as auxiliary medical personnel.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze